Plasma Concentration Feedback for Radiation Dose Timing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current radiation oncology systems, such as boron neutron capture therapy (BNCT) systems, inaccurately estimate the dose rate due to not considering the patient's drug concentration in plasma, leading to potential underestimation or overestimation of the delivered dose.

Innovation Solution

A dose control system that calculates the corrected dose rate distribution based on real-time drug concentration in plasma using correction coefficients, and adjusts the irradiation time accordingly to ensure accurate dose delivery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If the dose rate is estimated without considering real drug concentration in plasma, then the calculation process is simple, but the dose delivery accuracy deteriorates

Engineering Contradiction:
Improvecalculation process complexityVSAvoiddose delivery accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The system implements feedback by measuring the real drug concentration in plasma and using it to correct the dose rate calculation. The correction coefficient is determined based on the measured drug concentration, creating a closed-loop system that continuously adjusts the dose rate to match actual patient conditions, thereby resolving the contradiction between simple calculation and accurate dose delivery.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system changes the parameter used for dose rate calculation from a fixed theoretical drug concentration to a variable real drug concentration measured from the patient. By introducing a correction coefficient that varies with actual drug concentration levels, the system adapts the calculation to reflect real physiological conditions, improving dose accuracy without requiring completely new calculation methodologies.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If the theoretical drug concentration is used for dose rate estimation, then the system operation is simple, but the reliability of dose delivery deteriorates

Engineering Contradiction:
Improvesystem operation simplicityVSAvoiddose delivery reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The system introduces a correction coefficient as an intermediary element between the theoretical dose rate calculation and the actual dose delivery. This correction coefficient is determined based on real drug concentration measurements and serves as a bridge that adjusts the theoretical values to reflect actual patient conditions, thereby improving reliability while maintaining the simplicity of the underlying calculation framework.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Difficulty of detecting and measuring

If the dose rate is calculated without real-time drug concentration data, then the measurement process is simple, but the precision of dose rate estimation deteriorates

Engineering Contradiction:
Improvemeasurement process complexityVSAvoiddose rate estimation precision
Core Design Contradiction:
Difficulty of detecting and measuringVSMeasurement precision

Solution Approach 1:

The system employs feedback by continuously measuring real drug concentration in plasma and using this information to correct the dose rate estimation. The measured drug concentration feeds back into the calculation process through the correction coefficient, creating a self-adjusting system that improves dose rate precision while keeping the measurement process relatively simple through the use of established correction relationships.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12508443B2Dose control system
Publication Date: 2025.12.30 HERON NEUTRON MEDICAL CORP
  • US12508443B2 patent drawing
  • US12508443B2 patent drawing
  • US12508443B2 patent drawing

AI summary

A dose control system, including a processing device configured to obtain the real drug concentration in plasma of a patient. The processing device is further configured to calculate the corrected dose rate distribution datum based on the real drug concentration in plasma and a set of correction coefficients. The processing device is further configured to calculate the irradiation time based on the corrected dose rate distribution datum and the prescribed dose distribution datum. The processing device is further configured to control the irradiation device to irradiate the patient for the irradiation time.